Steven R. Pacelli - 08 Mar 2023 Form 4 Insider Report for DEXCOM INC (DXCM)

Reporting relationship: EVP Managing Director Dexcom V
Issuer ticker: DXCM
Reported as of: 08 Mar 2023
Net transaction value: +$18.78
SEC form: 4
Accepted by SEC: 10 Mar 2023, 14:58:31 UTC
Prior SEC filing: 23 Feb 2023
Next SEC filing: 14 Mar 2023
Source filing: View source filing
Reporting owner signature: By: Jereme Sylvain For: Steven R Pacelli

Key filing fact

Steven R. Pacelli filed Form 4 for DEXCOM INC (DXCM) on 10 Mar 2023.

Key facts

This page summarizes Steven R. Pacelli's Form 4 filing for DEXCOM INC (DXCM).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 10 Mar 2023, 14:58.

Change

Previous filing in this sequence was filed on 23 Feb 2023.
Current net transaction value: +$18.78.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DXCM transaction

Common Stock

Award

Transaction value: $18.78
Shares: +18,776
Change %: +14%
Price: $0.001000^*
Shares after: 155,240
Date: 08 Mar 2023
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.

Footnote F2

Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024.